TickerFacts.

ZyVersa Therapeutics, Inc. (ZVSA): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$12.39M
As of 2025-12-31
-$14.12M
As of 2026-03-31
$99.68M2021-12-31: -$2.26M2022-12-12: $99.68M2023-12-31: $11.07M2024-12-31: $8.52M2025-12-31: -$12.39M-$12.39M
2021-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$12.39Mn/m2026-03-31, Balance as of period end
2024-12-31$8.52M-23.1%2026-03-31, Balance as of period end
2023-12-31$11.07Mn/a2025-03-27, Balance as of period end
2022-12-12$99.68Mn/a2024-03-25, Balance as of period end
2021-12-31-$2.26Mn/a2022-04-15, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
ZyVersa Therapeutics, Inc. (ZVSA)2025-12-31-$12.39Mn/m
Bespoke Extracts, Inc. (BSPK)2024-12-31-$2.09Mn/m
Polomar Health Services, Inc. (PMHS)2025-12-31-$1.22Mn/m
America Great Health (AAGH)2025-06-30-$5.66Mn/m
Cell Source, Inc. (CLCS)2024-12-31-$18.54Mn/m
Bio Essence Corp (BIOE)2025-12-31-$2.07Mn/m
Regen BioPharma Inc (RGBP)2025-09-30-$6.28Mn/m
ProtoKinetix, Inc. (PKTX)2025-12-31$297.9K-12.9%
Bioadaptives, Inc. (BDPT)2025-12-31-$2.13Mn/m

Compare ZVSA, BSPK, PMHS, AAGH side by side · Screen every company in Pharmaceutical Preparations ↗